Walgreens Now Offers Next-Day Rx Delivery Service With FedEx
Currently, same-day delivery is available only in Dallas, Chicago, New York City, Gainesville, Miami, Tampa, and Fort Lauderdale; this program will be expanded in 2019.
All articles by Da Hee Han
Limited Doses of FDA-Approved EpiPen Generic Now Available
The generic version of the EpiPen Jr (epinephrine injection, USP) 0.15mg as well as additional supply of the generic version of the EpiPen Auto-Injector 0.3mg will be made available in 2019.
First Rituximab Biosimilar Truxima Gets FDA Approval
The FDA approval was supported by clinical data describing structural and functional characterization, preclinical data, human pharmacokinetic data, clinical immunogenicity data, and other data which showed no clinically meaningful differences between Truxima and Rituxan.
Male Contraceptive Gel to Be Evaluated in Clinical Trial
The year-long Phase 2b trial, funded by the National Institutes of Health, will enroll approximately 420 couples that are seeking pregnancy prevention across 3 US sites (Los Angeles, Seattle, and Kansas City).
Hypertension Combo Pill Recalled Due to Presence of Probable Carcinogen
Losartan Potassium and Hydrochlorothiazide Tablets are approved to treat hypertension, alone or in combination with other antihypertensive drugs.
HHS: Updated Physical Activity Guidelines for Americans Released
This guidance, updated for the first time since 2008, provides evidence-based recommendations for children (ages 3-17) and adults.
Several Asthma, Allergy Groups Express “Deep Concern” Over Primatene MIST Approval
Primatene MIST was approved earlier this month for over-the-counter (OTC) use for the temporary relief of mild symptoms of intermittent asthma (eg, wheezing, tightness of chest, shortness of breath) in patients aged ≥12 years.
FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
The 23andMe Personal Genome Service Pharmacogenetic Reports test can detect 33 variants for multiple genes, corresponding to more than 50 commonly prescribed medications and over-the-counter products.
FDA Approves Diagnostic Test to Help Determine Menopausal Status
The FDA’s marketing approval was supported by data from 690 women (aged 42 to 62 years) who were enrolled in the Study of Women’s Health Across the Nation.
Ready-to-Use Glucagon Rescue Pen Under FDA Review for Severe Hypoglycemia Tx
The NDA included findings from multiple Phase 3 trials evaluating the safety, efficacy, and utility of the Xeris glucagon rescue pen auto-injector to treat severe hypoglycemia vs currently available glucagon emergency kits in children, adolescents, and adults with type 1 diabetes.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...